Breast care pathway
Breast Ultrasound
Invenia ABUS 2.0 for dense breasts
Clinical evidence is growing about the effectiveness of ultrasound for finding small, node-negative, invasive cancers that may be missed by mammography1. Patient-friendly Invenia™ ABUS 2.0 is the first FDA-approved ultrasound supplemental screening technology that is specifically designed for detecting cancer in dense breast tissue.
LOGIQ E10 Series Ultrasound
The LOGIQ™ E10 Series helps you make a real difference in the lives of patients with breast disease. The systems’ cSound™ Architecture provides images of excellent detail and contrast resolution for greater diagnostic confidence, while new AI-based workflow tools help increase exam efficiency.
LOGIQ Fortis™ Ultrasound
The GE LOGIQ Fortis™ ultrasound is built to help clinicians deliver on the promise of confident care in breast imaging. Small and sleek enough to move to patients throughout your facility and equipped with our most powerful technology, it is GE’s affordable all-in-one solution.
REFERENCES
- 1. Mandelson et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000; 92:1081–1087.
- 2. FDA PMA P110006 summary of safety and effectiveness